Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
01/2008
01/01/2008US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors
01/01/2008US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1
01/01/2008US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds
01/01/2008US7314877 Benzofuran derivative
01/01/2008US7314876 Administering to mammals nitrogen compounds, as mitogen activated kinase inhibitors, for prophylaxis asthma, respiratory system disorders, graft versus host disease, atherosclerosis and arthritis
01/01/2008US7314873 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents
01/01/2008US7314731 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents
01/01/2008US7314629 Inducing an immune response towards the HPV-16 Papillomavirus native E7 protein, without simultaneously inducing an immunosuppression; cancers associated with an infection
12/2007
12/27/2007WO2007149523A2 Hexahydro-isoalpha acid based protein kinase modulation cancer treatment
12/27/2007WO2007149512A2 Peptide epoxyketones for pr0teas0me inhibition
12/27/2007WO2007149505A2 Beta acid based protein kinase modulation cancer treatment
12/27/2007WO2007149504A2 Isoalpha acid based protein kinase modulation cancer treatment
12/27/2007WO2007149503A2 Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
12/27/2007WO2007149482A2 Xanthohumol based protein kinase modulation cancer treatment
12/27/2007WO2007149481A2 Tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
12/27/2007WO2007149480A2 Reduced isoalpha acid based protein kinase modulation cancer treatment
12/27/2007WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative
12/27/2007WO2007148697A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor
12/27/2007WO2007147646A1 OXO-SUBSTITUTED IMIDAZO[1,2b]PYRIDAZINES, PRODUCTION AND USE THEREOF AS DRUGS
12/27/2007WO2007147623A2 A novel target in the treatment of cytokine release syndrome
12/27/2007WO2007126727A3 WATER SOLUBLE β-GLUCAN, GLUCOSAMINE, AND N-ACETYLGLUCOSAMINE COMPOSITIONS AND METHODS FOR MAKING THE SAME
12/27/2007WO2007125321A3 Purine and deazapurine derivatives as pharmaceutical compounds
12/27/2007WO2007125315A3 Pharmaceutical compounds
12/27/2007WO2007110761A8 Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof
12/27/2007WO2003066824A3 Albumin-fused kunitz domain peptides
12/27/2007US20070299111 Benzamide derivatives and uses related thereto
12/27/2007US20070299105 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use
12/27/2007US20070299095 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
12/27/2007US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent
12/27/2007US20070299073 Imidazolyl derivatives
12/27/2007US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity
12/27/2007US20070299050 TNF alpha inhibitors; inflammatory diseases such as rheumatoid arthritis, Crohn's disease, septic shock syndrome and atherosclerosis
12/27/2007US20070299049 Pharmaceutical Uses of Staurosporine Derivatives
12/27/2007US20070299018 Derivatives of Genkwanin and Sakuranetin, Cosmetic and Therapeutic Use Thereof and Preparation Method of Same
12/27/2007US20070298124 ammonium trichloro(dioxyethylene-O,O')tellurate; epilepsy, inflammatory bowel disease, Crohn's disease and ulcerative colits
12/27/2007US20070298094 Medicinal Composition, Preparation and Combined Preparation
12/27/2007US20070298076 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
12/27/2007US20070298051 Adjuvants Of Immune Response
12/27/2007US20070298048 Non-viral gene delivery system
12/27/2007US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
12/27/2007US20070298035 Recombinant immunoglobulin for targeting, treatment and prevention of cancer, transplant rejection and viral infection
12/27/2007US20070298020 Apoptotic entities for use in treatment of endothelium dysfunction disorders
12/27/2007US20070298016 Methods For The Generation Of Hepatocyte-Like Cells From Human Blastocyst-Derived Stem (Hbs)
12/27/2007US20070298011 Use of parasitic biological agents for prevention and control of autoimmune diseases
12/27/2007US20070297989 Novel anti-inflammatory androstane derivatives
12/27/2007DE4447972B4 Pharmaceutical preparations contg macrolide antibiotics - contain, as the carrier, a mixt of a hydrophilic phase, a lipophilic phase and a surfactant
12/27/2007DE102006029447A1 Oxo-substituierte Imidazo[1,2b]pyridazine, deren Herstellung und Verwendung als Arzneimittel Oxo-substituted imidazo [1,2-b] pyridazines, their preparation and use as medicaments
12/27/2007CA2659124A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
12/27/2007CA2657213A1 Peptide epoxyketones for proteasome inhibition
12/27/2007CA2656413A1 Oxo-substituted imidazo[1,2b]pyridazines, their preparation and use as pharmaceuticals
12/27/2007CA2655043A1 Tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
12/26/2007EP1870452A1 Process for production of regulatory t cell
12/26/2007EP1870422A1 Means for the treatment of diseases characterized by an excessive immune reaction
12/26/2007EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
12/26/2007EP1870091A1 Liposome composition for induction of immunity
12/26/2007EP1869195A2 Macromolecule obtained from a bifidobacterium culture and use thereof for the prevention and treatment of inflammatory rheumatisms
12/26/2007EP1869161A1 Method for the preparation of anallergic probiotic bacterial cultures and related use
12/26/2007EP1868646A2 Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent
12/26/2007EP1868642A2 Cat allergen fusion proteins and uses thereof
12/26/2007EP1868622A1 Selection and use of lactic acid bacteria for reducing inflammation in mammals
12/26/2007EP1868612A2 Novel compounds
12/26/2007EP1333810B1 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
12/26/2007EP1235596B1 Use of lytic toxins and toxin conjugates
12/26/2007EP0996710B1 Component of bromelain
12/26/2007CN101092453A Therapeutic compounds comprised of anti-fc receptor binding agents
12/26/2007CN101092397A Structure modified compound of sinomenine, and prepartion method
12/26/2007CN101092388A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
12/26/2007CN101091795A Prevention and treatment of synucleinopathic disease
12/26/2007CN101091789A Application of ocean collagen peptide in preparing medicine or foodstuff for adjusting immunity
12/26/2007CN101091750A Chinese traditional medicine of oral medication for treating heady urticaria
12/26/2007CN101091726A Composition of health care composed of Cordyceps militaris and unsaturated oligosaccharide aldehydic acid
12/26/2007CN100357324C Effectors of innate immunity
12/26/2007CN100357308C Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
12/26/2007CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
12/26/2007CN100357244C Aspirin-triggered lipid mediators
12/26/2007CN100356967C Health Luling vinegar and its preparing process
12/25/2007US7312373 Nonhuman model animal lacking the ability to control lymphocyte migration
12/25/2007US7312344 Dimeric isoflavones
12/25/2007US7312341 Kinase inhibitors; rheumatic diseases; antiarthritic agents
12/25/2007US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders
12/25/2007US7312321 Antibody to human enzymes of the metalloprotease family
12/25/2007US7312234 Chemokine receptor binding heterocyclic compounds
12/25/2007US7312232 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/25/2007US7312230 Carboxylic acid derivatives as IP antagonists
12/25/2007US7312224 Pyrimidine derivatives
12/25/2007US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis
12/25/2007US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/25/2007US7311905 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
12/21/2007WO2007146602A1 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
12/21/2007WO2007145282A1 Therapeutic or prophylactic agent for allergic dermatitis
12/21/2007WO2007145192A1 Collagen type iv-like immunoreactive peptide
12/21/2007WO2007144943A1 Composition for enhancing immune function
12/21/2007WO2007144397A1 Induction of tolerance to egg proteins
12/21/2007WO2007144198A2 Fplr-1 inhibitors for use in diseases involving amyloid-induced inflammatory events (flipr and flipr-like) and immunecomplex-mediated diseases
12/21/2007WO2007085451A3 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti -inflammatory agents
12/21/2007WO2007081288A9 Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
12/21/2007WO2007081287A9 Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
12/21/2007WO2007064620A3 Compositions comprising a combination of ccr5 and cxcr4 antagonists
12/21/2007WO2003063903A3 Modulation of t lymphocytes using dp iv inhibitors
12/21/2007CA2655372A1 Il-17 and il-23 antagonists and methods of using the same
1 ... 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 ... 1172